TY  - GEN
AU  - Benhamou,Ygal
AU  - Paintaud,Gilles
AU  - Azoulay,Elie
AU  - Poullin,Pascale
AU  - Galicier,Lionel
AU  - Desvignes,Céline
AU  - Baudel,Jean-Luc
AU  - Peltier,Julie
AU  - Mira,Jean-Paul
AU  - Pène,Frédéric
AU  - Presne,Claire
AU  - Saheb,Samir
AU  - Deligny,Christophe
AU  - Rousseau,Alexandra
AU  - Féger,Frédéric
AU  - Veyradier,Agnès
AU  - Coppo,Paul
TI  - Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study
SN  - 1096-8652
PY  - 2017///0621
KW  - ADAMTS13 Protein
KW  - blood
KW  - Adult
KW  - B-Lymphocytes
KW  - drug effects
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Historically Controlled Study
KW  - Humans
KW  - Lymphocyte Depletion
KW  - Male
KW  - Middle Aged
KW  - Plasma Exchange
KW  - Platelet Count
KW  - Purpura, Thrombotic Thrombocytopenic
KW  - drug therapy
KW  - Rituximab
KW  - administration & dosage
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ajh.24559
ER  -